21.95
price down icon1.79%   -0.40
after-market Dopo l'orario di chiusura: 21.95
loading
Precedente Chiudi:
$22.35
Aprire:
$22.44
Volume 24 ore:
222.82K
Relative Volume:
0.46
Capitalizzazione di mercato:
$1.08B
Reddito:
-
Utile/perdita netta:
$-85.21M
Rapporto P/E:
-11.61
EPS:
-1.89
Flusso di cassa netto:
$-68.53M
1 W Prestazione:
-5.96%
1M Prestazione:
+3.73%
6M Prestazione:
+0.41%
1 anno Prestazione:
-8.58%
Intervallo 1D:
Value
$21.80
$22.83
Intervallo di 1 settimana:
Value
$21.38
$24.38
Portata 52W:
Value
$13.30
$30.03

Enliven Therapeutics Inc Stock (ELVN) Company Profile

Name
Nome
Enliven Therapeutics Inc
Name
Telefono
720-647-8519
Name
Indirizzo
6200 LOOKOUT ROAD, BOULDER
Name
Dipendente
65
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ELVN's Discussions on Twitter

Confronta ELVN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ELVN
Enliven Therapeutics Inc
21.95 1.27B 0 -85.21M -68.53M -1.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-16 Iniziato Goldman Buy
2024-12-13 Iniziato BTIG Research Buy
2024-09-09 Iniziato H.C. Wainwright Buy
2024-06-11 Iniziato Robert W. Baird Outperform
2024-04-09 Iniziato Mizuho Buy
2023-03-29 Iniziato Jefferies Buy
Mostra tutto

Enliven Therapeutics Inc Borsa (ELVN) Ultime notizie

pulisher
Jul 24, 2025

Polis encourages life-sciences companies to move to Colorado - BizWest

Jul 24, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Enliven Therapeutics Inc. stockOutstanding investment returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Enliven Therapeutics Inc. a good long term investmentTriple-digit growth rates - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics CSO sells $278k in shares - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics CSO sells $278k in shares By Investing.com - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics’ Promising CML Study Update: What Investors Need to Know - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Enliven Therapeutics Inc. stock priceOutstanding capital growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Samuel Kintz Sells 12,500 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

Why Enliven Therapeutics Inc. stock attracts strong analyst attentionDaily Price Surge List - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

Can Enliven Therapeutics, Inc. (ELVN) Climb 75.66% to Reach the Level Wall Street Analysts Expect? - MSN

Jul 20, 2025
pulisher
Jul 19, 2025

Enliven Therapeutics’ Promising Phase 1a/1b Study on ELVN-002 in HER2+ Cancers - The Globe and Mail

Jul 19, 2025
pulisher
Jul 19, 2025

Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Enliven Therapeutics (ELVN) - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

Will Enliven Therapeutics Inc. stock split in the near futureTop Performing Low Risk Stocks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Enliven Therapeutics’ Promising CML Treatment: A Study Update - TipRanks

Jul 17, 2025
pulisher
Jul 15, 2025

What makes Enliven Therapeutics Inc. stock price move sharplyFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Enliven Therapeutics Inc. stock performs during market volatilityInsider Strategy Insight - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

(ELVN) Proactive Strategies - news.stocktradersdaily.com

Jul 15, 2025
pulisher
Jul 15, 2025

Enliven Therapeutics CFO Hohl sells $22,655 in shares - Investing.com Australia

Jul 15, 2025
pulisher
Jul 14, 2025

Brokerages Set Enliven Therapeutics, Inc. (NASDAQ:ELVN) Target Price at $41.20 - Defense World

Jul 14, 2025
pulisher
Jul 10, 2025

Enliven Therapeutics Breaks Above 200-Day Moving AverageBullish for ELVN - Nasdaq

Jul 10, 2025
pulisher
Jul 09, 2025

Enliven Therapeutics COO Patel sells shares worth $131950 By Investing.com - Investing.com Canada

Jul 09, 2025
pulisher
Jul 09, 2025

Enliven Therapeutics COO Patel sells shares worth $131950 - Investing.com

Jul 09, 2025
pulisher
Jul 05, 2025

HC Wainwright Brokers Increase Earnings Estimates for ELVN - Defense World

Jul 05, 2025
pulisher
Jul 04, 2025

(ELVN) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 04, 2025

Enliven Therapeutics Inc Azioni (ELVN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):